Full Press Release Details
NASHVILLE, Tenn. & SAN CARLOS, Calif.--(BUSINESS WIRE)---- $ONC #BeOne--CLL Society, a leading authority for chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL) patients, and BeOne Medicines, a global oncology company, today announced an expanded, multi-year partnership focused on strengthening education, engagement, and access to trusted resources across the CLL/SLL community. John V. Oyler, Co-Founder, Chairman and CEO, BeOne Medicines, said: “No two individuals with CLL or SLL are the sa